C12Y 302/01103
Keratan-sulfate endo-1,4-beta-galactosidase
Official title: Keratan-sulfate endo-1,4-beta-galactosidase (3.2.1.103)
C12Y302/01103 (Keratan-sulfate endo-1,4-beta-galactosidase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 17 Apr 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- An agent, a device and a blood-circulation system for treating lysosomal storage diseases, and a method for treating lysosomal storage diseases2 Jul 2020US 2020/0206323 A1Seikagaku Corporation
- Cellulose-degrading enzyme composition comprising gh1619 Nov 2015US 2015/0329841 A1Iogen Energy Corporation
- Sperm activating agent and activating method using same3 Sep 2015US 2015/0245852 A1National University Corporation Hamamatsu University School of Medicine
Most cited
By later US patents